{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:11:16Z","timestamp":1790140276368,"version":"4.0.1"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.neuint.2024.105771","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T07:03:55Z","timestamp":1715843035000},"page":"105771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Amino acid transporters in neurological disorders and neuroprotective effects of cysteine derivatives"],"prefix":"10.1016","volume":"177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9354-903X","authenticated-orcid":false,"given":"Santosh Kumar","family":"Adla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinileena","family":"Virtanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanavit","family":"Thongsodsaeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiina M.","family":"Huttunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2024.105771_bib1","first-page":"125","article-title":"Characterization of a novel mutation in SLC1A1 associated with schizophrenia","volume":"1","author":"Afshari","year":"2015","journal-title":"Mol. Neuropsychiatry"},{"key":"10.1016\/j.neuint.2024.105771_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183854","article-title":"Reduced Slc1a1 expression is associated with neuroinflammation and impaired sensorimotor gating and cognitive performance in mice: implications for schizophrenia","volume":"12","author":"Afshari","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2024.105771_bib3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1017\/S1740925X11000093","article-title":"Roles of glutamine in neurotransmission","volume":"6","author":"Albrecht","year":"2010","journal-title":"Neuron Glia Biol."},{"key":"10.1016\/j.neuint.2024.105771_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nn1609","article-title":"Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse","volume":"9","author":"Aoyama","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2024.105771_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1254\/jphs.08R01CR","article-title":"Regulation of neuronal glutathione synthesis","volume":"108","author":"Aoyama","year":"2008","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neuint.2024.105771_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S0033291700028099","article-title":"Autism as a strongly genetic disorder: evidence from a British twin study","volume":"25","author":"Bailey","year":"1995","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuint.2024.105771_bib7","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/sj.npp.1301532","article-title":"Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine","volume":"33","author":"Baker","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuint.2024.105771_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","article-title":"The blood-brain barrier: an overview: structure, regulation, and clinical implications","volume":"16","author":"Ballabh","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2024.105771_bib9","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022863","article-title":"Glutamatergic mechanisms associated with seizures and epilepsy","volume":"5","author":"Barker-Haliski","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.neuint.2024.105771_bib10","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1074\/jbc.M111.315705","article-title":"Glutathione degradation is a key determinant of glutathione homeostasis","volume":"287","author":"Baudouin-Cornu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2024.105771_bib11","doi-asserted-by":"crossref","first-page":"12079","DOI":"10.1073\/pnas.96.21.12079","article-title":"Selective expression of the large neutral amino acid transporter at the blood-brain barrier","volume":"96","author":"Boado","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2024.105771_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0169-328X(01)00113-9","article-title":"Differential expression of the cationic amino acid transporter 2(B) in the adult rat brain","volume":"91","author":"Braissant","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuint.2024.105771_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1476-5381.2011.01480.x","article-title":"System xc\u207b cystine\/glutamate antiporter: an update on molecular pharmacology and roles within the CNS","volume":"165","author":"Bridges","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2024.105771_bib14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1369\/jhc.5A6840.2006","article-title":"Distribution of the cystine\/glutamate antiporter system xc- in the brain, kidney, and duodenum","volume":"54","author":"Burdo","year":"2006","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.neuint.2024.105771_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.semcdb.2015.03.008","article-title":"Cysteine string protein (CSP) and its role in preventing neurodegeneration","volume":"40","author":"Burgoyne","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.neuint.2024.105771_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1036","article-title":"Abnormalities in the genes that encode large amino acid transporters increase the risk of autism spectrum disorder","volume":"8","author":"Cascio","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.neuint.2024.105771_bib17","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.cell.2015.07.022","article-title":"A call for systematic research on solute carriers","volume":"162","author":"Cesar-Razquin","year":"2015","journal-title":"Cell (Cambridge, MA, U. S.)"},{"key":"10.1016\/j.neuint.2024.105771_bib18","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1046\/j.1471-4159.2003.01630.x","article-title":"The glutamate transporters EAAT2 and EAAT3 mediate cysteine uptake in cortical neuron cultures","volume":"84","author":"Chen","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2024.105771_bib19","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1016\/S0021-9258(18)99417-2","article-title":"A distinct Na+-requiring transport system for alanine, serine, cysteine, and similar amino acids","volume":"242","author":"Christensen","year":"1967","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2024.105771_bib20","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","article-title":"Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline","volume":"30","author":"Clinton","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2024.105771_bib21","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1039\/C6MD00005C","article-title":"SLC transporters: structure, function, and drug discovery","volume":"7","author":"Colas","year":"2016","journal-title":"Medchemcomm"},{"key":"10.1016\/j.neuint.2024.105771_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuint.2015.06.011","article-title":"On the antioxidant, neuroprotective and anti-inflammatory properties of S-allyl cysteine: an update","volume":"89","author":"Col\u00edn-Gonz\u00e1lez","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2024.105771_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176197","article-title":"The role of amino acids in neurotransmission and fluorescent tools for their detection","volume":"21","author":"Dalangin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2024.105771_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.1976.sp011267","article-title":"Review lecture. The blood-brain barrier","volume":"255","author":"Davson","year":"1976","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuint.2024.105771_bib25","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1042\/bj20021785","article-title":"L-serine in disease and development","volume":"371","author":"De Koning","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuint.2024.105771_bib26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1152\/physrev.1998.78.2.487","article-title":"Transporters for cationic amino acids in animal cells: discovery, structure, and function","volume":"78","author":"Dev\u00e9s","year":"1998","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuint.2024.105771_bib27","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1046\/j.1460-9568.2000.00229.x","article-title":"Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo","volume":"12","author":"Do","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2024.105771_bib28","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.neuint.2024.105771_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ymgme.2016.04.010","article-title":"Serine biosynthesis and transport defects","volume":"118","author":"El-Hattab","year":"2016","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.neuint.2024.105771_bib30","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1046\/j.1471-4159.1998.71062565.x","article-title":"Glutamine uptake at the blood-brain barrier is mediated by N-system transport","volume":"71","author":"Ennis","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2024.105771_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0002-8223(94)92045-1","article-title":"Dietary amino acids and brain function","volume":"94","author":"Fernstrom","year":"1994","journal-title":"J. Am. Diet Assoc."},{"key":"10.1016\/j.neuint.2024.105771_bib32","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/265726a0","article-title":"Genetic influences and infantile autism","volume":"265","author":"Folstein","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2024.105771_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156551","article-title":"D-serine is a substrate for neutral amino acid transporters ASCT1\/slc1a4 and ASCT2\/slc1a5, and is transported by both subtypes in rat hippocampal astrocyte cultures","volume":"11","author":"Foster","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2024.105771_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mam.2012.10.007","article-title":"The SLC3 and SLC7 families of amino acid transporters","volume":"34","author":"Fotiadis","year":"2013","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.neuint.2024.105771_bib35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1471-4159.2004.02726.x","article-title":"Cystamine increases l-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation","volume":"91","author":"Fox","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2024.105771_bib36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neuint.2014.06.017","article-title":"Dysregulation of system xc(-) expression induced by mutant huntingtin in a striatal neuronal cell line and in R6\/2 mice","volume":"76","author":"Frederick","year":"2014","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2024.105771_bib37","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.bcp.2012.09.010","article-title":"N-Acetylcysteine ethyl ester (NACET): a novel lipophilic cell-permeable cysteine derivative with an unusual pharmacokinetic feature and remarkable antioxidant potential","volume":"84","author":"Giustarini","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuint.2024.105771_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114786","article-title":"Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: opportunities for novel therapeutics development","volume":"193","author":"Green","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuint.2024.105771_bib39","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1007\/s11064-016-1996-8","article-title":"Amino acid promoieties alter valproic acid pharmacokinetics and enable extended brain exposure","volume":"41","author":"Gynther","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuint.2024.105771_bib40","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2024.105771_bib41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrn.2015.19","article-title":"Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis","volume":"17","author":"Hardingham","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2024.105771_bib42","doi-asserted-by":"crossref","first-page":"218S","DOI":"10.1093\/jn\/136.1.218S","article-title":"Structure of the blood\u2013brain barrier and its role in the transport of amino Acids1, 2, 3","volume":"136","author":"Hawkins","year":"2006","journal-title":"J. Nutr."},{"key":"10.1016\/j.neuint.2024.105771_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41582-021-00595-5","article-title":"Neurogenetic disorders across the lifespan: from aberrant development to degeneration","volume":"18","author":"Hickman","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuint.2024.105771_bib44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0006-8993(99)01686-8","article-title":"Neuron-specific expression of cationic amino acid transporter 3 in the adult rat brain","volume":"838","author":"Hosokawa","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2024.105771_bib45","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1002\/jnr.21710","article-title":"N-acetylcysteine prevents \u03b2-amyloid toxicity by a stimulatory effect on p35\/cyclin-dependent kinase 5 activity in cultured cortical neurons","volume":"86","author":"Hsiao","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuint.2024.105771_bib46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.fct.2005.08.012","article-title":"Protective effect of s-allyl cysteine and s-propyl cysteine on acetaminophen-induced hepatotoxicity in mice","volume":"44","author":"Hsu","year":"2006","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.neuint.2024.105771_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1043384","article-title":"CSP\u03b1 in neurodegenerative diseases","volume":"14","author":"Huang","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuint.2024.105771_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22189718","article-title":"Cystine\/glutamate antiporter in schizophrenia: from molecular mechanism to novel biomarker and treatment","volume":"22","author":"Hung","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2024.105771_bib49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/BJ20040243","article-title":"Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression","volume":"381","author":"Ishii","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuint.2024.105771_bib50","doi-asserted-by":"crossref","first-page":"23629","DOI":"10.1074\/jbc.273.37.23629","article-title":"Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98)","volume":"273","author":"Kanai","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2024.105771_bib51","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.mam.2013.01.001","article-title":"The SLC1 high-affinity glutamate and neutral amino acid transporter family","volume":"34","author":"Kanai","year":"2013","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.neuint.2024.105771_bib52","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1016\/S0021-9258(19)85625-9","article-title":"Characteristics of an amino acid transport system in rat liver for glutamine, asparagine, histidine, and closely related analogs","volume":"255","author":"Kilberg","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2024.105771_bib53","first-page":"1565","article-title":"Neuroprotective mechanisms of S-allyl-L-cysteine in neurological disease","volume":"19","author":"Kosuge","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.neuint.2024.105771_bib54","doi-asserted-by":"crossref","first-page":"C1101","DOI":"10.1152\/ajpcell.1998.274.4.C1101","article-title":"Glutamine transport by the blood-brain barrier: a possible mechanism for nitrogen removal","volume":"274","author":"Lee","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuint.2024.105771_bib55","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1523\/JNEUROSCI.5865-09.2010","article-title":"Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington's disease","volume":"30","author":"Li","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2024.105771_bib56","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jpsychires.2015.10.007","article-title":"Decreased mRNA expression for the two subunits of system xc(-), SLC3A2 and SLC7A11, in WBC in patients with schizophrenia: evidence in support of the hypo-glutamatergic hypothesis of schizophrenia","volume":"72","author":"Lin","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuint.2024.105771_bib57","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.clinbiochem.2006.11.019","article-title":"Oxidative stress markers in surgically treated patients with refractory epilepsy","volume":"40","author":"L\u00f3pez","year":"2007","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.neuint.2024.105771_bib58","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/jnc.13723","article-title":"Perturbed proteostasis in autism spectrum disorders","volume":"139","author":"Louros","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2024.105771_bib59","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.bbagen.2012.09.008","article-title":"Glutathione synthesis","volume":"1830","author":"Lu","year":"2013","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.neuint.2024.105771_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2019.00025","article-title":"D-serine: potential therapeutic agent and\/or biomarker in schizophrenia and depression?","volume":"10","author":"Mackay","year":"2019","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuint.2024.105771_bib61","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s41745-018-0081-5","article-title":"Transporters through the looking glass. An insight into the mechanisms of ion-coupled transport and methods that help reveal them","volume":"98","author":"Majumder","year":"2018","journal-title":"J. Indian Inst. Sci."},{"key":"10.1016\/j.neuint.2024.105771_bib62","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/emboj\/21.4.580","article-title":"Activation of system L heterodimeric amino acid exchangers by intracellular substrates","volume":"21","author":"Meier","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.neuint.2024.105771_bib63","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12974-016-0787-0","article-title":"Absence of system x(c)(-) on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis","volume":"14","author":"Merckx","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuint.2024.105771_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157602","article-title":"N-acetyl cysteine may support dopamine neurons in Parkinson's disease: preliminary clinical and cell line data","volume":"11","author":"Monti","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2024.105771_bib65","doi-asserted-by":"crossref","first-page":"12452","DOI":"10.1073\/pnas.1818521116","article-title":"Hypoxia-induced switch in SNAT2\/SLC38A2 regulation generates endocrine resistance in breast cancer","volume":"116","author":"Morotti","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2024.105771_bib66","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuroscience.2015.11.010","article-title":"The serotonin system in autism spectrum disorder: from biomarker to animal models","volume":"321","author":"Muller","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2024.105771_bib67","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ajmg.b.32125","article-title":"Deletion at the SLC1A1 glutamate transporter gene co-segregates with schizophrenia and bipolar schizoaffective disorder in a 5-generation family","volume":"162b","author":"Myles-Worsley","year":"2013","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.neuint.2024.105771_bib68","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/jmedgenet-2015-103104","article-title":"Mutations in <em>SLC1A4<\/em>, encoding the brain serine transporter, are associated with developmental delay, microcephaly and hypomyelination","volume":"52","author":"Nadirah","year":"2015","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuint.2024.105771_bib69","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00018-021-04074-4","article-title":"The role of SLC transporters for brain health and disease","volume":"79","author":"Nguyen","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuint.2024.105771_bib70","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4834117","article-title":"Cysteine donor-based brain-targeting prodrug: opportunities and challenges","volume":"2022","author":"Ni","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuint.2024.105771_bib71","doi-asserted-by":"crossref","first-page":"31891","DOI":"10.1074\/jbc.274.45.31891","article-title":"Na(+)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal","volume":"274","author":"O'kane","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2024.105771_bib72","doi-asserted-by":"crossref","first-page":"E622","DOI":"10.1152\/ajpendo.00187.2004","article-title":"Na+ -dependent neutral amino acid transporters A, ASC, and N of the blood-brain barrier: mechanisms for neutral amino acid removal","volume":"287","author":"O'kane","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.neuint.2024.105771_bib73","doi-asserted-by":"crossref","first-page":"E412","DOI":"10.1152\/ajpendo.00007.2006","article-title":"Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+","volume":"291","author":"O'kane","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.neuint.2024.105771_bib74","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3181\/00379727-149-38889","article-title":"Greater number of capillary endothelial cell mitochondria in brain than in muscle","volume":"149","author":"Oldendorf","year":"1975","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.neuint.2024.105771_bib75","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejmech.2016.03.019","article-title":"The cysteine releasing pattern of some antioxidant thiazolidine-4-carboxylic acids","volume":"114","author":"\u00d6nen Bayram","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuint.2024.105771_bib76","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neulet.2004.03.072","article-title":"Preventive effect of antioxidants in MPTP-induced mouse model of Parkinson's disease","volume":"363","author":"Park","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2024.105771_bib77","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/ars.2014.5917","article-title":"Modes of physiologic H2S signaling in the brain and peripheral tissues","volume":"22","author":"Paul","year":"2015","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.neuint.2024.105771_bib78","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature13136","article-title":"Cystathionine \u03b3-lyase deficiency mediates neurodegeneration in Huntington's disease","volume":"509","author":"Paul","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2024.105771_bib79","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tips.2018.02.007","article-title":"Cysteine metabolism in neuronal redox homeostasis","volume":"39","author":"Paul","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuint.2024.105771_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11082117","article-title":"L-Serine: neurological implications and therapeutic potential","volume":"11","author":"Phone Myint","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuint.2024.105771_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00122","article-title":"S-sulfocysteine induces seizure-like behaviors in zebrafish","volume":"10","author":"Plate","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2024.105771_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/children10020412","article-title":"Neuroactive amino acid profile in autism spectrum disorder: results from a clinical sample","volume":"10","author":"Randazzo","year":"2023","journal-title":"Children"},{"key":"10.1016\/j.neuint.2024.105771_bib83","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/jcbfm.2011.21","article-title":"Differential axial localization along the mouse brain vascular tree of luminal sodium-dependent glutamine transporters Snat1 and Snat3","volume":"31","author":"Ruderisch","year":"2011","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuint.2024.105771_bib84","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1523\/JNEUROSCI.23-02-00550.2003","article-title":"Neutral amino acid transporter ASCT1 is preferentially expressed in L-Ser-synthetic\/storing glial cells in the mouse brain with transient expression in developing capillaries","volume":"23","author":"Sakai","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2024.105771_bib85","doi-asserted-by":"crossref","first-page":"25951","DOI":"10.1016\/S0021-9258(18)35701-6","article-title":"Neutral amino acid transport by the blood-brain barrier. Membrane vesicle studies","volume":"267","author":"S\u00e1nchez Del Pino","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2024.105771_bib86","doi-asserted-by":"crossref","first-page":"14913","DOI":"10.1074\/jbc.270.25.14913","article-title":"Neutral amino acid transport characterization of isolated luminal and abluminal membranes of the blood-brain barrier","volume":"270","author":"S\u00e1nchez Del Pino","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2024.105771_bib87","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/jama.2017.12141","article-title":"The heritability of autism spectrum disorder","volume":"318","author":"Sandin","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.neuint.2024.105771_bib88","doi-asserted-by":"crossref","first-page":"11455","DOI":"10.1074\/jbc.274.17.11455","article-title":"Cloning and expression of a plasma membrane cystine\/glutamate exchange transporter composed of two distinct proteins","volume":"274","author":"Sato","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2024.105771_bib89","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0165-0270(95)00038-V","article-title":"Effects of L-serine on neurons in vitro","volume":"61","author":"Savoca","year":"1995","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuint.2024.105771_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.944861","article-title":"Editorial: brain abnormalities due to genetic alterations or developmental exposure to environmental factors","volume":"16","author":"Sawada","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuint.2024.105771_bib91","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1073\/pnas.1608264113","article-title":"Transcriptional control of amino acid homeostasis is disrupted in Huntington's disease","volume":"113","author":"Sbodio","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2024.105771_bib92","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/pro.320","article-title":"Comparison of human solute carriers","volume":"19","author":"Schlessinger","year":"2010","journal-title":"Protein Sci."},{"key":"10.1016\/j.neuint.2024.105771_bib93","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1074\/jbc.M112.441022","article-title":"Molecular determinants for functional differences between alanine-serine-cysteine transporter 1 and other glutamate transporter family members","volume":"288","author":"Scopelliti","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2024.105771_bib94","doi-asserted-by":"crossref","first-page":"17468","DOI":"10.1074\/jbc.M114.565242","article-title":"Na+ interactions with the neutral amino acid transporter ASCT1","volume":"289","author":"Scopelliti","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2024.105771_bib95","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.22-03-j0004.2002","article-title":"Aberrant expression of the glutamate transporter excitatory amino acid transporter 1 (EAAT1) in Alzheimer's disease","volume":"22","author":"Scott","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2024.105771_bib96","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neuint.2011.03.025","article-title":"Role of oxidative stress in epileptic seizures","volume":"59","author":"Shin","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2024.105771_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111297","article-title":"Compounds that extend longevity are protective in neurodegenerative diseases and provide a novel treatment strategy for these devastating disorders","volume":"190","author":"Soo","year":"2020","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.neuint.2024.105771_bib98","doi-asserted-by":"crossref","first-page":"24017","DOI":"10.1074\/jbc.271.39.24017","article-title":"Induced nitric oxide synthesis is dependent on induced alternatively spliced CAT-2 encoding L-arginine transport in brain astrocytes","volume":"271","author":"Stevens","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2024.105771_bib99","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mvr.2017.12.003","article-title":"Developmental changes of l-arginine transport at the blood-brain barrier in rats","volume":"117","author":"Tachikawa","year":"2018","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.neuint.2024.105771_bib100","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.cell.2016.11.013","article-title":"Impaired amino acid transport at the blood brain barrier is a cause of autism spectrum disorder","volume":"167","author":"T\u0103rlungeanu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2024.105771_bib101","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1471-4159.2003.02063.x","article-title":"The l-isomer-selective transport of aspartic acid is mediated by ASCT2 at the blood-brain barrier","volume":"87","author":"Tetsuka","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2024.105771_bib102","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1086\/507566","article-title":"Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene","volume":"79","author":"Tosic","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuint.2024.105771_bib103","doi-asserted-by":"crossref","first-page":"14883","DOI":"10.1074\/jbc.271.25.14883","article-title":"Cloning and functional characterization of a system ASC-like Na+-dependent neutral amino acid transporter","volume":"271","author":"Utsunomiya-Tate","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2024.105771_bib104","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/j.1460-2075.1986.tb04382.x","article-title":"The function of tight junctions in maintaining differences in lipid composition between the apical and the basolateral cell surface domains of MDCK cells","volume":"5","author":"Van Meer","year":"1986","journal-title":"EMBO J."},{"key":"10.1016\/j.neuint.2024.105771_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010119","article-title":"Amino acid transport defects in human inherited metabolic disorders","volume":"21","author":"Yahyaoui","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2024.105771_bib106","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-019-1011-z","article-title":"Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex","volume":"568","author":"Yan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2024.105771_bib107","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1155\/2006\/248387","article-title":"Altered glutathione redox state in schizophrenia","volume":"22","author":"Yao","year":"2006","journal-title":"Dis. Markers"},{"key":"10.1016\/j.neuint.2024.105771_bib108","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3389\/fphys.2020.00973","article-title":"Transport of amino acids across the blood-brain barrier","volume":"11","author":"Zaragoz\u00e1","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.neuint.2024.105771_bib109","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00018-020-03483-1","article-title":"Regulation of branched-chain amino acid metabolism by hypoxia-inducible factor in glioblastoma","volume":"78","author":"Zhang","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuint.2024.105771_bib110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00726-016-2332-y","article-title":"Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literature","volume":"49","author":"Zheng","year":"2017","journal-title":"Amino Acids"}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018624000986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018624000986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T16:29:24Z","timestamp":1717259364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018624000986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":110,"alternative-id":["S0197018624000986"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2024.105771","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amino acid transporters in neurological disorders and neuroprotective effects of cysteine derivatives","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2024.105771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105771"}}